In vitro activities of benzimidazoles against Echinococcus multilocularis metacestodes

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 5, 1998, Pages 1052-1056

  Jura, Heike ^a   Bader, Augustinus ^b   Frosch, Matthias ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTHELMINTIC AGENT; BENZIMIDAZOLE DERIVATIVE; MEBENDAZOLE;

ANTHELMINTIC ACTIVITY; ARTICLE; DOSE TIME EFFECT RELATION; DRUG ACTIVITY; DRUG EFFICACY; DRUG SENSITIVITY; ECHINOCOCCOSIS; ECHINOCOCCUS MULTILOCULARIS; LIVER CELL; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; SURVIVAL RATE;

EID: 0031959012     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.5.1052     Document Type: Article

References (31)

1. Ammann, R., K. Tschudi, M. von Ziegler, F. Meister, J. Cotting, J. Eckert, and F. Witassek. 1988. Langzeitverlauf bei 60 Patienten mit alveolärer Echinokokkose unter Dauertherapie mit Mebendazol. Klin. Wochenschr. 66:1060-1073.
2. Ammann, R., N. Ilitsch, B. Marincek, and A. U. Freiburghaus. 1993. Effect of chemotherapy on the larval mass and on the long-term course of alveolar echinococcosis. Hepatology 19:735-742.
3. Ammann, R. W. 1991. Improvement of liver resectional therapy by adjuvant chemotherapy in alveolar hydatid disease. Parasitol. Res. 77:290-293.
4. Ammann, R. W., R. Hirsbrunner, J. Cotting, U. Steiger, P. Jaquier, and J. Eckert. 1990. Recurrence rate after discontinuation of long-term mebendazole therapy in alveolar echinococcosis (preliminary results). Am J. Trop. Med. Hyg. 43:506-515.
5. Cook, G. C. 1990. Use of benzimidazole chemotherapy in human helminthiases: indications and efficacy. Parasitol. Today 6:133-136.
6. Dunn, J. C. Y., R. G. Tompkins, and M. L. Yarmush. 1991. Long-term in vitro function of adult hepatocytes in a collagen sandwich configuration. Biotechnol. Prog. 7:237-245.
7. Eckert, J., and R. W. Ammann. 1995. Clinical diagnosis and treatment of echinococcosis in humans, p. 411-463. In R. C. A. Thompson and A. J. Lymbery (ed.), Echinococcus and hydatid disease. CAB International Wallingford, England.
8. Eckert, J., and J. Pohlenz. 1976. Zur Wirkung von Mebendazol auf Metazestoden von Mesocestoides corti und Echinococcus multilocularis Tropenmed. Parasitol. 27:247-262.
9. Frosch, P. M., M. Frosch, T. Pfister, V. Schaad, and D. Bitter-Suermann. 1991. Cloning and characterisation of an immunodominant major surface antigen of Echinococcus multilocularis. Mol. Biol. Parasitol. 48:121-130.
10. Heath, D. D., M. J. Christie, and R. A. F. Chevis. 1975. The lethal effect of mebendazole on secondary Echinococcus granulosus cysticerci and Taenis pisiformis and tetrathyridia of Mesocestoides corti. Parasitology 70:273-285.
11. Horton, R. J. 1989. Chemotherapy of Echinococcus infection in man with albendazole. Trans. R. Soc. Trop. Med. Hyg. 83:97-102.
12. Jura, H., A. Bader, M. Hartmann, H. J. Maschek, and M. Frosch. 1996. Hepatic tissue culture model for study of host-parasite interactions in alveolar echinococcosis. Infect. Immun. 64:3484-3490.
13. Kern, P., P. Frosch, M. Helbig, J. G. Wechsler, S. Usadel, K. Beckh, R. Kunz, R. Lucius, and M. Frosch. 1995. Diagnosis of Echinococcus multilocularis infection by reverse-transcription polymerase chain reaction. Gastroenterology 109:596-600.
14. Lacey, E. 1988. The role of the cytoskeletal protein, tubulin, in the mode of action and mechanism of the drug resistance to benzimidazoles. Int. J. Parasitol. 18:885-936.
15. Lacey, E. 1990. Mode of action of benzimidazoles. Parasitol. Today 6:112-115.
16. Löscher, T., F. von Sonnenburg, and H. D. Nothdurft. 1992. Epidemiology and therapy of human echinococcosis in central Europe. In 8th International Congress for Tropical Medicine and Malaria.
17. Luder, P. J., G. Robotti, F. P. Meister, and J. Bircher. 1985. High oral doses of mebendazole interfere with growth of larval Echinococcus multilocularis lesions. J. Hepatol. 1:369-377.
18. Luder, P. J., B. Siffert, F. Wittassek, F. Meister, and J. Bircher. 1986. Treatment of hydatid disease with high oral doses of mebendazole. Long-term follow-up of plasma mebendazole levels and drug interactions. Eur. J. Pharmacol. 31:443-448.
19. Marriner, S. E., D. L. Morris, B. Dickson, and J. A. Bogan. 1986. Pharmacokinetics of albendazole in man. Eur. J. Clin. Pharmacol. 30:705-708.
20. Rausch, R. L. 1995. Life cycle patterns and geographic distribution of Echinococcus spezies, p. 89-134. In R. C. A. Thompson and A. J. Lymbery (ed.), Echinococcus and hydatid disease. CAB International, Wallingford, England.
21. Roos, M. H. 1990. The molecular nature of benzimidazole resistance. Parasitol. Today 6:125-127.
22. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
23. Schantz, P. M., H. Van den Bossche, and J. Eckert. 1982. Chemotherapy for larval echinococcosis in animals and humans: report of a workshop. Z. Parasitenkunde. 53:5-26.
24. Schantz, P. M., F. H. Brandt, C. M. Dickinson, C. R. Allen, J. M. Roberts, and M. L. Eberhard. 1990. Effects of albendazole on Echinococcus multilocularis infection in the Mongolian jird. J. Infect. Dis. 162:1403-1407.
25. Schicker, H. J. 1976. Die Echinokokkose des Menschen. Stand der Diagnostik, Therapie und Prognose bei Echinokokkenerkrankungen in Baden-Württemberg in den Jahren 1960-72. Medical dissertation. University of Tübingen, Tübingen, Germany.
26. Seglen, P. O. 1976. Preparation of isolated rat liver cells. Methods Cell Biol. 13:29-83.
27. Teggi, A., M. G. Lastilla, and F. De Rosa. 1993. Therapy of human hydatid disease with mebendazole and albendazole. Antimicrob. Agents Chemother. 37:1679-1684.
28. Van den Bossche, H. 1986. Mode of action of anticestodal agents, p. 139-157. In W. C. Campbell and R. S. Rew (ed.), Chemotherapy of parasitic diseases. Plenum Press, New York, N.Y.
29. Waller, P. J. 1990. Resistence in nematode parasites of livestock to the benzimidazole antihelmintics. Parasitol. Today 6:127-129.
30. Wilson, J. F., R. L. Rausch, B. J. McMahon, and P. M. Schantz. 1992. Parasitocidal effect of chemotherapy in alveolar hydatid disease: review of experience with mebendazole and albendazole in Alaskan Eskimos. Clin. Infect. Dis. 15:234-249.
31. Wilson, J. F., R. L. Rausch, and F. R. Wilson. 1995. Alveolar hydatide disease. Review of the surgical experience in 42 cases of active disease among Alaskan eskimos. Ann. Surg. 221:315-323.